Mirtaz 7.5 Tablet
Prescription Required
Product introduction
Mirtaz 7.5 Tablet is used in the treatment of depression. This medicine works by increasing the level of chemical messengers (serotonin and noradrenaline) in the brain that help calm the brain and relax the nerves, thus treating your depression.
Mirtaz 7.5 Tablet is used to treat depression.
Mirtaz 7.5 Tablet is used to treat depression.
Uses of Mirtaz Tablet
Benefits of Mirtaz Tablet
In Treatment of Depression
Mirtaz 7.5 Tablet helps in maintaining the balance of certain chemicals in the brain that affect mood and behavior. This improves your mood, relieves anxiety, tension, helps you sleep better, and increases your energy levels. Mirtaz 7.5 Tablet prevents extreme mood changes and helps you feel less agitated. You may experience fewer episodes of depression and low mood.
It can take several weeks for Mirtaz 7.5 Tablet to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
It can take several weeks for Mirtaz 7.5 Tablet to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
Side effects of Mirtaz Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mirtaz
- Sleepiness
- Dryness in mouth
- Increased appetite
- Headache
- Weight gain
How to use Mirtaz Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mirtaz 7.5 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Mirtaz 7.5 Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Mirtaz 7.5 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Mirtaz 7.5 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
The baby should be monitored for behavioral side effects and adequate growth.
The baby should be monitored for behavioral side effects and adequate growth.
Driving
UNSAFE
Mirtaz 7.5 Tablet may cause side effects which could affect your ability to drive.
Mirtaz 7.5 Tablet can affect your concentration or alertness. This may impair your driving ability.
Mirtaz 7.5 Tablet can affect your concentration or alertness. This may impair your driving ability.
Kidney
CAUTION
Mirtaz 7.5 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mirtaz 7.5 Tablet may be needed. Please consult your doctor.
Liver
CAUTION
Mirtaz 7.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Mirtaz 7.5 Tablet may be needed. Please consult your doctor.
What if you forget to take Mirtaz Tablet?
If you miss a dose of Mirtaz 7.5 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Mirtaz 7.5 Tablet
₹4.5/Tablet
Mirnite 7.5mg Tablet
Intas Pharmaceuticals Ltd
₹7.65/tablet
70% costlier
Mirtee 7.5mg Tablet
Talent India
₹4.73/tablet
5% costlier
Mirtakem 7.5mg Tablet
Alkem Laboratories Ltd
₹7.75/tablet
72% costlier
Mirtadep 7.5mg Tablet
Torrent Pharmaceuticals Ltd
₹5.66/tablet
26% costlier
Mirza 7.5mg Tablet
Nusearch Organic
₹7.79/tablet
73% costlier
Quick tips
- Mirtaz 7.5 Tablet starts to work more quickly than other antidepressants.
- Avoid driving or operating dangerous machinery as it may decrease alertness.
- Avoid consuming alcohol when taking the Mirtaz 7.5 Tablet, as it may cause excessive drowsiness and calmness.
- If your doctor asks you to stop Mirtaz 7.5 Tablet, you should reduce the dose slowly over 4 weeks. You should not discontinue it abruptly.
- Notify your doctor immediately if you develop a sore throat or fever or stomatitis during treatment with Mirtaz 7.5 Tablet.
Fact Box
Chemical Class
Piperazinoazepine Tetracyclic
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Noradrenergic and specific serotonergic antidepressants (NASSAs)
Patient concerns
User feedback
Patients taking Mirtaz 7.5 Tablet
Once A Day
94%
Twice A Day
4%
Alternate Day
1%
What are you using Mirtaz Tablet for?
Others
100%
How much was the improvement?
Average
100%
What were the side-effects while using Mirtaz 7.5 Tablet?
No Side Effec*
100%
*No Side Effect
FAQs
Is Mirtaz 7.5 Tablet addictive?
No, Mirtaz 7.5 Tablet is not addictive. Patient should follow the advice of the doctor regarding its use
Is Mirtaz 7.5 Tablet safe?
Mirtaz 7.5 Tablet is safe if used at prescribed dose and duration as advised by your doctor
Can I take Mirtaz 7.5 Tablet forever?
No, patient should take Mirtaz 7.5 Tablet for the given duration as advised by your doctor
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Mirtazapine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 441-45.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 925-26.
- Mirtazapine. Salt Lake City, Utah: Cephalon, Inc.; 2015. [Accessed 25 Mar 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Mirtazapine. [Updated 2019 Apr 1]. [Accessed 20 Feb. 2020] (online) Available from:
- Mirtazapine. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2006 [revised 15 Oct. 2018]. [Accessed 25 Mar 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 25 Mar. 2019] (online) Available from:
Marketer details
Name: Sun Pharmaceutical Industries Ltd
Address: Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
Country of origin: India
Lab tests offered by us
Related/Popular tests
20,656 people viewed this recentlyNOT FOR SALE
We do not facilitate sale of this product at present